Sten Madsbad

Sten Madsbad

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
441 - 450 out of 476Page size: 10
Sort by: 1st author
  1. Published

    In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans

    Toräng, S., Bojsen-Møller, K. N., Svane, M. S., Hartmann, Bolette, Rosenkilde, Mette, Madsbad, Sten & Holst, Jens Juul, 27 Jan 2016, In: A J P: Regulatory, Integrative and Comparative Physiology (Online). 310, 1, p. R866-R874 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Major rapid weight loss induces changes in cardiac repolarization

    Vedel-Larsen, E., Iepsen, E. P. W., Lundgren, J., Graff, C., Struijk, J. J., Hansen, Torben, Holst, Jens Juul, Madsbad, Sten, Torekov, Signe Sørensen & Kanters, Jørgen K., 10 Feb 2016, In: Journal of Electrocardiology. 49, 3, p. 467-472 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Increased glucose-stimulated FGF21 response to oral glucose in obese non-diabetic subjects after Roux-en-Y Gastric Bypass

    Vienberg, S. G., Jacobsen, S. H., Worm, D., Hvolris, L. E., Naver, L. P. S., Almdal, Thomas Peter, Hansen, D. L., Wulff, B. S., Clausen, T. R., Madsbad, Sten, Holst, Jens Juul & Andersen, B., Jan 2017, In: Clinical Endocrinology. 86, 1, p. 156-159 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

    Vilsbøll, T., Krarup, T., Sonne, J., Madsbad, Sten, Vølund, A., Juul, A. G. & Holst, Jens Juul, Jun 2003, In: The Journal of clinical endocrinology and metabolism. 88, 6, p. 2706-13 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

    Vilsbøll, Tina, Krarup, T., Sonne, J., Madsbad, Sten, Vølund, A., Juul, Anders, Holst, J. M. & Juul, A. G., 1 Jun 2003, In: Journal of Clinical Endocrinology and Metabolism. 88, 6, p. 2706-13 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

    Vilsbøll, Tina, Krarup, T., Madsbad, Sten & Holst, J. M., 1 Aug 2002, In: Diabetologia. 45, 8, p. 1111-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.

    Vilsbøll, Tina, Agersø, H., Lauritsen, T., Deacon, Carolyn F., Aaboe, K., Madsbad, Sten, Krarup, T. & Holst, Jens Juul, 2006, In: Regulatory Peptides. 137, 3, p. 168-72 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

    Vilsbøll, Tina, Knop, Filip Krag, Krarup, T., Johansen, A., Madsbad, Sten, Larsen, S., Hansen, T., Pedersen, O., Holst, J. M. & Johansen, A., 1 Oct 2003, In: Journal of Clinical Endocrinology and Metabolism. 88, 10, p. 4897-903 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients

    Vilsbøll, Tina, Krarup, T., Deacon, C. F., Madsbad, Sten & Holst, J. M., 1 Mar 2001, In: Diabetes. 50, 3, p. 609-613 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

    Vilsbøll, T., Krarup, T., Madsbad, Sten & Holst, Jens Juul, 15 Jul 2003, In: Regulatory Peptides. 114, 2-3, p. 115-21 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...41 42 43 44 45 46 47 48 Next

ID: 10877